Načítá se...
Intravenous iron in inflammatory bowel disease
The prevalence of anemia across studies on patients with inflammatory bowel disease (IBD) is high (30%). Both iron deficiency (ID) and anemia of chronic disease contribute most to the development of anemia in IBD. The prevalence of ID is even higher (45%). Anemia and ID negatively impact the patient...
Uloženo v:
Hlavní autoři: | , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
The WJG Press and Baishideng
2009
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2754515/ https://ncbi.nlm.nih.gov/pubmed/19787830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.4666 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|